CMV poses a significant public health burden due to its association with congenital infections and its impact on immunocompromised individuals. It contributes to healthcare costs through the need for diagnostics, treatment, and long-term care for affected children. Public health strategies focus on awareness campaigns, research into vaccines, and guidelines for the management of CMV in at-risk populations.